Optimal management of asymptomatic carotid
stenosis in 2021: the jury is still out. An international,
multispecialty, expert review and position statement
#VascularMedicine
DOI: 10.23736/S0392-9590.21.04825-2
Revascularisation is important but not everything for PAD: Management of chronic PAD patients with indication for endovascular revascularization - A position paper by ESVM
@ESVM_@JillBelch@MarianneBrodma1#VascularMedicine @AngiologieCHUV
https://t.co/fdXHoUK2hY
Every angioplasty causes dissections. We are happy w luminal gain and dismiss vessel wall damage. Can vessel prep help? Our early histologic results of orbital atherectomy is encouraging but bottom line: we need more histologic data! @DeBakeyCVedu
Novel cardiovascular biomarkers associated with peripheral arterial disease in men screened for abdominal aortic aneurysm. Interesting novel bio markers detected, but need more research #PAD#VascularMedicine https://t.co/mrI2BTs7kc
@DanHan@MSHSSurgery wow. how exciting it must be to learn there. As an aspiring and passionate vascular surgeon it is inspiring to see so many ways to train in the field. I hope to reach that goal. Congratulations 👏🏻
"[We] have focused our energy on maintaining the highest quality of coverage of the field, while improving the presentation and value for the readership in the 10th edition through a very contemporary approach." - Bruce A. Perler, MD, MBA https://t.co/v9IrCjsE9Y
@OHSUvascular @TzeWoeiTan Great news. It is exciting to see the number of integrated vascular surgery programs increase. For those of us who are passionate about vascular surgery and aspire to enter an integrated residency, it is very exciting. big steps. Congrats 👏🏻
Ribaroxaban increasingly involved in PAD. VOYAGE-PAD trial present. It will be interesting to observe the results in the dual management with aspirin after the first 5 years have elapsed. Big steps.
RIVAROXABAN REDUCES HOSPITALIZATIONS FOR THROMBOEMBOLIC EVENTS IN PATIENTS
WITH PERIPHERAL ARTERY DISEASE AFTER REVASCULARIZATION IN THOSE WITH AND WITHOUT
CHRONIC KIDNEY DISEASE
https://t.co/gnQO3B6K12
#VascularMedicine
Impact of Cardiac Function on Loss of Patency in Patients With Peripheral Artery Disease. Cardiac function ie reduced stroke volume & chronic heart failure & smaller distal reference vessel diameter associated with loss of 12-month primary patency in #PAD https://t.co/xxzfGFhNDY
Interesting data on venous thrombotic events after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone #PAD https://t.co/6JvjQqbk40
While the presence of inflammatory bowel disease increases the risk for a venous thromboembolic event in affected patients, thrombophilia doesn't play a role in the pathway of increased risk. Study in @JCGjournal#gastroenterology@IBD_GorenMD@Iris_Dotan
https://t.co/UY7082bI40